Apellis Pharmaceuticals, Inc. financial data

Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Fifth Avenue, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 397 % -21.2%
Quick Ratio 70.6 % +26.3%
Debt-to-equity 256 % +28.3%
Return On Equity -104 % +50.3%
Return On Assets -29.2 % +58.2%
Operating Margin -31.2 % +85.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares +4.97%
Common Stock, Shares, Outstanding 122M shares +3.14%
Entity Public Float 10.7B USD +123%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 124M shares +3.28%
Weighted Average Number of Shares Outstanding, Diluted 124M shares +3.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 715M USD +162%
Research and Development Expense 320M USD -16.7%
General and Administrative Expense 501M USD +80.7%
Operating Income (Loss) -223M USD +62.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -248M USD +59.2%
Income Tax Expense (Benefit) 2.3M USD +154%
Net Income (Loss) Attributable to Parent -250M USD +58.7%
Earnings Per Share, Basic -2 USD/shares +62%
Earnings Per Share, Diluted -2 USD/shares +62%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 397M USD -12.3%
Marketable Securities, Current 124M USD -15.1%
Accounts Receivable, after Allowance for Credit Loss, Current 279M USD +64.8%
Inventory, Net 121M USD +22.8%
Other Assets, Current 11.8M USD -61.8%
Assets, Current 834M USD +4.66%
Property, Plant and Equipment, Net 3.38M USD -29.5%
Operating Lease, Right-of-Use Asset 17.1M USD +10.2%
Other Assets, Noncurrent 1.45M USD +23.4%
Assets 902M USD +10.2%
Accounts Payable, Current 42.7M USD +135%
Accrued Liabilities, Current 140M USD +19.4%
Liabilities, Current 191M USD +3.03%
Operating Lease, Liability, Noncurrent 11.4M USD +4.88%
Other Liabilities, Noncurrent 9.83M USD +939%
Liabilities 665M USD +13.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.14M USD -195%
Retained Earnings (Accumulated Deficit) -3B USD -9.1%
Stockholders' Equity Attributable to Parent 237M USD +2.09%
Liabilities and Equity 902M USD +10.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -133M USD +25.1%
Net Cash Provided by (Used in) Financing Activities 108M USD -72.3%
Net Cash Provided by (Used in) Investing Activities -293K USD -13.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 122M shares +3.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.3M USD -112%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 398M USD -12.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.64M USD 0%
Deferred Tax Assets, Valuation Allowance 753M USD +18.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 756M USD +18%
Operating Lease, Liability 18.2M USD +9.53%
Depreciation 444K USD +5.46%
Payments to Acquire Property, Plant, and Equipment 293K USD +13.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -252M USD +58.3%
Lessee, Operating Lease, Liability, to be Paid 19.7M USD +6.36%
Operating Lease, Liability, Current 6.79M USD +18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.76M USD +26.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.42M USD +14.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -13.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.5M USD -21.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.06M USD -53%
Deferred Tax Assets, Operating Loss Carryforwards 329M USD +43.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 859K USD -79.9%
Operating Lease, Payments 2.31M USD +14.3%
Additional Paid in Capital 3.24B USD +8.62%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%